SHR6390 Combined With Anastrozole for Preoperative Treatment of Breast Cancer.
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: SHR6390+anatrozole
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Collaborators: Jiangsu HengRui Medicine Co., Ltd.